
GNE基因相关血小板减少症1例报道并文献复习
GNE gene-related thrombocytopenia: a case report and literature review
目的 分析GNE基因相关血小板减少症的临床特征和诊疗效果。 方法 回顾性分析1例GNE基因相关血小板减少症患儿资料并归纳文献报道病例,对临床表型和诊疗特点进行分析。 结果 31例患儿主要起病于新生儿或儿童早期,表现为皮肤黏膜出血,26例伴巨大血小板,4例成年后进展为GNE肌病。总体疗效欠佳,5例对促血小板生成药物应答良好。 结论 GNE基因相关血小板减少症以中重度血小板减少、巨大血小板及出血倾向为特征,部分患儿可继发GNE肌病,需早期识别并探索有效疗法。
Objective To study the clinical characteristics and treatment outcomes of GNE gene-related thrombocytopenia. Methods A retrospective analysis was conducted on the data of one child with GNE gene-related thrombocytopenia, along with a review of cases reported in the literature, focusing on clinical phenotypes and treatment characteristics. Results Among 31 patients, the onset was primarily in the neonatal period or early childhood, characterized by mucocutaneous bleeding. Twenty-six cases presented with macrothrombocytes, and 4 cases progressed to GNE myopathy in adulthood. Overall treatment efficacy was suboptimal, although 5 cases responded well to thrombopoietic agents. Conclusions GNE gene-related thrombocytopenia is characterized by moderate to severe thrombocytopenia, macrothrombocytes, and a bleeding tendency. Some children may develop secondary GNE myopathy, highlighting the need for early identification and exploration of effective therapies.
血小板减少 / GNE基因突变 / 先天性血小板减少症 / 新生儿
Thrombocytopenia / GNE gene mutation / Congenital thrombocytopenia / Neonate
1 |
|
2 |
|
3 |
李晨, 陈正, 陈鸣艳, 等. 2日龄新生儿高胆红素血症合并血小板减少[J]. 中国当代儿科杂志, 2019, 21(12): 1218-1222. PMCID: PMC7389015. DOI: 10.7499/j.issn.1008-8830.2019.12.013 .
|
4 |
5 |
|
6 |
|
7 |
中华医学会儿科学分会血液学组. 儿童遗传性血栓性血小板减少性紫癜诊断与治疗专家共识[J]. 中华儿科杂志, 2023, 61(4): 310-316. DOI: 10.3760/cma.j.cn112140-20220908-00788 .
|
8 |
|
9 |
|
10 |
|
11 |
|
12 |
|
13 |
|
14 |
|
15 |
|
16 |
|
17 |
|
18 |
|
19 |
|
20 |
|
21 |
|
22 |
|
23 |
|
24 |
|
25 |
|
26 |
|
27 |
|
28 |
|
29 |
|
30 |
|
31 |
|
32 |
|
33 |
|
34 |
|
35 |
刘畅, 张巍, 王朝霞, 等. 空泡性肌纤维:不同疾病的病理差异[J]. 中华神经科杂志, 2022, 55(11): 1317-1324. DOI: 10.3760/cma.j.cn113694-20220211-00093 .
|
36 |
|
37 |
|
38 |
中华医学会血液学分会血栓与止血学组. 促血小板生成药物临床应用管理中国专家共识(2023年版)[J]. 中华血液学杂志, 2023, 44(7): 535-542. PMCID: PMC10509622. DOI: 10.3760/cma.j.issn.0253-2727.2023.07.002 .
|
39 |
|
40 |
|
林硕负责数据收集、整理、分析和文章撰写;陈晓娟负责文章的构思、设计与修改。